Apremilast Promising for Plaque Psoriasis
Long-Term Biologic Use May Not Raise Melanoma Risk
Should Biologic Therapy in Dermatology Be Interrupted During the Pandemic?
More Than Skin Deep: Insights into Clinical Challenges in Psoriatic Arthritis
Mirikizumab Promising for Plaque Psoriasis
EU Approves Marketing for Ixekizumab in Adults with PsA
Skin Exam Advised Before Anti-TNF-Alpha Therapy